JP Morgan Chase’s Zepp Health ZEPP Stock Holding History

JP Morgan Chase’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.1K	Buy	+100	New	+$2.05K	﹤0.01%	7107

Other funds holding ZEPP

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Monolith Management Hong Kong $332M AUM 119.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

YCM

Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return

JP Morgan Chase's ZEPP Position: Q3 2025 in Review

JP Morgan Chase sold out of Zepp Health (ZEPP) in Q3 2025, closing a stake of 231 shares — an estimated $614 sold.

JP Morgan Chase first reported a position in ZEPP in Q4 2018 and held it in 22 quarters. The position peaked at $1.22M in Q3 2020. 33 funds tracked by Wall St. Rank hold ZEPP as of Q3 2025.

JP Morgan Chase reported no remaining Zepp Health position as of Q3 2025 after selling out during the quarter.
JP Morgan Chase sold 231 Zepp Health shares in Q3 2025, an estimated $614.
JP Morgan Chase first reported a position in Zepp Health in Q4 2018 and held it in 22 quarters.
JP Morgan Chase's Zepp Health position peaked at $1.22M in Q3 2020.
33 funds tracked by Wall St. Rank held Zepp Health as of Q3 2025.

Based on JP Morgan Chase's 13F filing for Q3 2025, filed 7 Nov 2025.